Allergan and its Mohawk allies pitch their sovereign immunity case to SCOTUS. And the timing couldn't be worse
Allergan {AGN} is taking its case against inter partes review all the way to the Supreme Court — provided SCOTUS agrees to hear their attorneys.
The biotech company made its pitch to the Supreme Court alongside the Mohawk tribe that took the patents on Restasis, Allergan’s big blockbuster, as the company tried to wall itself off from generic manufacturers. But the courts, including a federal appeals court, have ruled against the company and the tribe.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.